Caredx Inc (CDNA)
CareDx, Inc. is a healthcare company focused on transplant patients and organ health in the United States and international markets. The company develops and commercializes diagnostic and monitoring solutions for kidney, heart, lung, and stem cell transplant care, including AlloSure Kidney, AlloMap Heart, AlloSure Heart, AlloSure Lung, HeartCare, HistoMap Kidney, and AlloHeme. Its portfolio also includes HLA typing and transplant management tools such as QTYPE, Olerup SSP, Ottr, AlloSeq Tx, AlloSeq cfDNA, AlloSeq HCT, Allocell, XynQAPI, MedActionPlan, CareDx pharmacy, AlloHome, and HLA Data Systems. CareDx also has a license agreement with Illumina covering the distribution, development, and commercialization of NGS products and technologies. The company, formerly known as XDx, Inc., was incorporated in 1998 and is headquartered in Brisbane, California.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-CDNA
|
$41.06
|
-27.3% Downside
|
Overvalued
|
$54.14
|
-4.2% Downside
|
Fair
|
Great
|
0.0%
|
November 10, 2026
|
26.3x
|
6.9x
|
6.4x
|
2.922 B
|
2.568 B
|
0.7%
|
95.6%
|
16.0
|
76.3%
|
